Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ENSIFENTRINE vs ROFLUMILAST: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ENSIFENTRINE vs ROFLUMILAST: Safety Overview

Metric ENSIFENTRINE ROFLUMILAST
Total FAERS Reports 410 2,700
Deaths Reported 2 645
Death Rate 0.5% 23.9%
Hospitalizations 77 625
Average Patient Age 71.7 yrs 68.8 yrs
% Female Patients 51.6% 56.3%
FDA Approval Date Jun 26, 2024 Apr 17, 2023
Manufacturer Verona Pharma, Inc. Aurobindo Pharma Limited
Route RESPIRATORY (INHALATION) ORAL
Marketing Status Prescription Prescription